CORBION NV (CRBN.AS) Stock Fundamental Analysis
AMS:CRBN - Euronext Amsterdam - NL0010583399 - Common Stock - Currency: EUR
We assign a fundamental rating of 6 out of 10 to CRBN. CRBN was compared to 62 industry peers in the Chemicals industry. While CRBN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CRBN is valued quite cheap, while showing a decent growth score. This is a good combination! This makes CRBN very considerable for value investing!
1. Profitability
1.1 Basic Checks
CRBN had positive earnings in the past year.
In the past year CRBN had a positive cash flow from operations.
In the past 5 years CRBN has always been profitable.
CRBN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CRBN has a better Return On Assets (12.43%) than 100.00% of its industry peers.
CRBN has a Return On Equity of 24.88%. This is amongst the best in the industry. CRBN outperforms 96.77% of its industry peers.
CRBN has a Return On Invested Capital of 6.89%. This is in the better half of the industry: CRBN outperforms 77.42% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRBN is in line with the industry average of 6.15%.
The 3 year average ROIC (6.62%) for CRBN is below the current ROIC(6.89%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.43% | ||
| ROE | 24.88% | ||
| ROIC | 6.89% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
1.3 Margins
With an excellent Profit Margin value of 14.92%, CRBN belongs to the best of the industry, outperforming 93.55% of the companies in the same industry.
In the last couple of years the Profit Margin of CRBN has grown nicely.
Looking at the Operating Margin, with a value of 7.04%, CRBN is in the better half of the industry, outperforming 67.74% of the companies in the same industry.
CRBN's Operating Margin has declined in the last couple of years.
CRBN's Gross Margin of 24.81% is in line compared to the rest of the industry. CRBN outperforms 43.55% of its industry peers.
CRBN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.04% | ||
| PM (TTM) | 14.92% | ||
| GM | 24.81% |
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CRBN is creating some value.
The number of shares outstanding for CRBN has been reduced compared to 1 year ago.
The number of shares outstanding for CRBN has been reduced compared to 5 years ago.
The debt/assets ratio for CRBN has been reduced compared to a year ago.
2.2 Solvency
CRBN has an Altman-Z score of 2.56. This is not the best score and indicates that CRBN is in the grey zone with still only limited risk for bankruptcy at the moment.
CRBN has a Altman-Z score of 2.56. This is in the better half of the industry: CRBN outperforms 66.13% of its industry peers.
CRBN has a debt to FCF ratio of 5.10. This is a neutral value as CRBN would need 5.10 years to pay back of all of its debts.
CRBN's Debt to FCF ratio of 5.10 is fine compared to the rest of the industry. CRBN outperforms 74.19% of its industry peers.
CRBN has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.40, CRBN is in line with its industry, outperforming 56.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | 5.1 | ||
| Altman-Z | 2.56 |
ROIC/WACC1.06
WACC6.48%
2.3 Liquidity
A Current Ratio of 1.17 indicates that CRBN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.17, CRBN is not doing good in the industry: 77.42% of the companies in the same industry are doing better.
A Quick Ratio of 0.58 indicates that CRBN may have some problems paying its short term obligations.
CRBN has a worse Quick ratio (0.58) than 87.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.17 | ||
| Quick Ratio | 0.58 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 168.39% over the past year.
Measured over the past years, CRBN shows a very strong growth in Earnings Per Share. The EPS has been growing by 49.47% on average per year.
CRBN shows a small growth in Revenue. In the last year, the Revenue has grown by 1.90%.
CRBN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.70% yearly.
EPS 1Y (TTM)168.39%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-47.64%
Revenue 1Y (TTM)1.9%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%4.6%
3.2 Future
Based on estimates for the next years, CRBN will show a very strong growth in Earnings Per Share. The EPS will grow by 27.50% on average per year.
CRBN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.97% yearly.
EPS Next Y55.4%
EPS Next 2Y34.31%
EPS Next 3Y27.5%
EPS Next 5YN/A
Revenue Next Year3.15%
Revenue Next 2Y3.69%
Revenue Next 3Y3.97%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 5.78 indicates a rather cheap valuation of CRBN.
98.39% of the companies in the same industry are more expensive than CRBN, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CRBN to the average of the S&P500 Index (28.88), we can say CRBN is valued rather cheaply.
With a Price/Forward Earnings ratio of 12.01, CRBN is valued correctly.
Based on the Price/Forward Earnings ratio, CRBN is valued cheaply inside the industry as 82.26% of the companies are valued more expensively.
CRBN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.20.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.78 | ||
| Fwd PE | 12.01 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CRBN is valued a bit cheaper than 67.74% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CRBN is valued cheaply inside the industry as 80.65% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.96 | ||
| EV/EBITDA | 8.69 |
4.3 Compensation for Growth
CRBN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CRBN may justify a higher PE ratio.
A more expensive valuation may be justified as CRBN's earnings are expected to grow with 27.50% in the coming years.
PEG (NY)0.1
PEG (5Y)0.12
EPS Next 2Y34.31%
EPS Next 3Y27.5%
5. Dividend
5.1 Amount
CRBN has a Yearly Dividend Yield of 3.50%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.07, CRBN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.45, CRBN pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
5.2 History
The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
5.3 Sustainability
CRBN pays out 21.80% of its income as dividend. This is a sustainable payout ratio.
CRBN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP21.8%
EPS Next 2Y34.31%
EPS Next 3Y27.5%
AMS:CRBN (4/30/2025, 7:00:00 PM)
18.79
+0.22 (+1.18%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners77.4%
Inst Owner ChangeN/A
Ins Owners0.21%
Ins Owner ChangeN/A
Market Cap1.09B
Analysts78.46
Price Target26.08 (38.8%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP21.8%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.79%
PT rev (3m)-5.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.41%
EPS NY rev (3m)3.7%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.93%
Revenue NY rev (3m)-1.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.78 | ||
| Fwd PE | 12.01 | ||
| P/S | 0.85 | ||
| P/FCF | 10.96 | ||
| P/OCF | 5.95 | ||
| P/B | 1.42 | ||
| P/tB | 1.63 | ||
| EV/EBITDA | 8.69 |
EPS(TTM)3.25
EY17.3%
EPS(NY)1.56
Fwd EY8.32%
FCF(TTM)1.72
FCFY9.13%
OCF(TTM)3.16
OCFY16.82%
SpS22.11
BVpS13.26
TBVpS11.56
PEG (NY)0.1
PEG (5Y)0.12
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.43% | ||
| ROE | 24.88% | ||
| ROCE | 8.18% | ||
| ROIC | 6.89% | ||
| ROICexc | 7.21% | ||
| ROICexgc | 7.95% | ||
| OM | 7.04% | ||
| PM (TTM) | 14.92% | ||
| GM | 24.81% | ||
| FCFM | 7.76% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexcg growth 3Y0.82%
ROICexcg growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score8
Asset Turnover0.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | 5.1 | ||
| Debt/EBITDA | 1.73 | ||
| Cap/Depr | 97% | ||
| Cap/Sales | 6.54% | ||
| Interest Coverage | 3.61 | ||
| Cash Conversion | 103.72% | ||
| Profit Quality | 51.98% | ||
| Current Ratio | 1.17 | ||
| Quick Ratio | 0.58 | ||
| Altman-Z | 2.56 |
F-Score8
WACC6.48%
ROIC/WACC1.06
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)168.39%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-47.64%
EPS Next Y55.4%
EPS Next 2Y34.31%
EPS Next 3Y27.5%
EPS Next 5YN/A
Revenue 1Y (TTM)1.9%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%4.6%
Revenue Next Year3.15%
Revenue Next 2Y3.69%
Revenue Next 3Y3.97%
Revenue Next 5YN/A
EBIT growth 1Y44.66%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year147.92%
EBIT Next 3Y43.91%
EBIT Next 5YN/A
FCF growth 1Y520.5%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y11.31%
OCF growth 3Y101.81%
OCF growth 5Y9.98%